Pharmacokinetics and Safety of Brexpiprazole Following Multiple-Dose Administration to Japanese Patients With Schizophrenia
Author:
Affiliation:
1. Institute of CNS Pharmacology; Shibuya-ku; Tokyo Japan
2. Headquarters of Clinical Development; Otsuka Pharmaceutical Co. Ltd., Chuo-ku; Osaka Japan
3. Department of Medical Affairs; Otsuka Pharmaceutical Co. Ltd., Minato-ku; Tokyo Japan
Funder
Otsuka Pharmaceutical
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference13 articles.
1. From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics;Correll;Eur Psychiatry,2010
2. Abilify Prescribing Information 2016
3. Otsuka Pharmaceutical Co Ltd ® 2015 http://www.accessdata.fda.gov
4. Otsuka Pharmaceutical Co Ltd TM 2017 http://www.healthcanada.gc.ca
5. Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator;Maeda;J Pharmacol Exp Ther,2014
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A multicenter, single‐arm, open‐label interventional study of adherence to brexpiprazole during switching from previous antipsychotic drugs in patients with schizophrenia or schizoaffective disorder;Neuropsychopharmacology Reports;2024-01-22
2. Brexpiprazole – Banishing Behavioral and Psychological Symptoms of Dementia;Journal of Psychiatry Spectrum;2023-12-29
3. Adjunctive brexpiprazole 1 mg and 2 mg daily for Japanese patients with major depressive disorder following inadequate response to antidepressants: a phase 2/3, randomized, double‐blind (BLESS) study;Psychiatry and Clinical Neurosciences;2023-12
4. The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off-target respiratory chain complex I inhibitors;Biology Direct;2023-08-01
5. The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off-target respiratory chain complex I inhibitors;2023-04-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3